M. Pacini, I. Maremmani, PISA-SIA - Vol. 7, Giugno 2001, num.2
Testo Bibliografia Summary Riassunto Indice
Il problema della personalità tossicofilica
nella patogenesi del Disturbo da Uso di Sostanze Psicoattive.
Revisione della Letteratura e recenti acquisizioni
The issue of toxicophilic personality in the pathogenesis of Psychoactive
Substance Use Disorder.
A review of literature and recent advances
1 Haddox V, Jacobson M. Psychological adjustment, mood and personality
fluctuations in long term methadone maintenance patients. Int J Addict
1972;7:619-27.
2 Korin H. Comparison of psychometric measures in psychiatric patients
using heroin and other drugs. J Abnorm Psychol 1974;83:208-12.
3 Nisle A, Robinowitz R, Penk JR. An empirical test of anhedonia in compulsive
use of illicit drugs. Dallas, Texas: VAMC, Drug Abuse Program 1979.
4 Platt JJ, Scurra W. Peer adjustment of parole success in institutionalized
heroin addicts: personality correlates and validity. J Consult Clin Psychol
1975;21:511-5.
5 Burger GK, Collins HA. Relationship between MMPI and CPI Types of Male
Heroin Abusers. Am J Drug Alcohol Abuse 1982;9:281-7.
6 Kurtines W, Hogan R, Weiss D. Personality dynamic of heroin use.
J Abnorm Psychol 1975;84:87-89.
7 Martin J, Ingles J. Pain tolerance and narcotic addiction. Br J Soc
Psychol 1965;4:224-9.
8 Roehric H, Gold MS. Diagnosis of substance abuse in an adolescent psychiatric
population. Int J Psychiatry Med 1986;16/2:137-43.
9 McLellan AT, Woody GE, O’Brien CP. Development of psychiatric illness
in drug abusers: Possible role of drug preference. N Engl J Med 1979;301:1310-4.
10 Dorus W, Senay EC. Depression demographic dimensions, and drug abuse.
Am J Psychiatry 1980;137:669-704.
11 Steer RA, Schut J. Affect dimension of male heroin addicts admitted
for inpatient detoxification. Int J Addict 1981;1:341-8.
12 Craig RJ. Personality characteristics of heroin addicts: A review of
the empirical literature with critique - Part II. Int J Addict 1979;14:607-26.
13 De Leon G, Rosenthal M, Brodney K. Therapeutic Community for drug addicts,
long term measurement of emotional changes. Psychol Rep 1971;29:595-600.
14 De Leon G, Skodon A, Rosenthal MS. Phoenix House. Changes in Psychopatology
signs of resident drug addicts. Arch Gen Psychiatry 1973;28:131-5.
15 De Leon G, Jainchill N. Male and Female drug abusers: serial and psychological
status 2 years after treatment in a therapeutic community. Am J Drug Alcohol
Abuse 1981;8/4:465-97.
16 De Leon G, Wexler HK, Jainchill N. The therapeutic community: success
and improvement rates 5 years after treatment. Int J Addict 1982;17/4:703-47.
17 Jacobs PE, Doft EB, Koger J. A study of SCL-90 scores of 264 methadone
patients in treatment. Int J Addict 1981;16:541-8.
18 Maremmani I, Daini L. Sintomi di Comorbidità Psichiatrica durante
il trattamento della dipendenza da eroina. Bollettino per le Farmacodipendenze
e l’Alcolismo (in stampa).
19 Rothaizer JM. Typological study of substance abusers using the MMPI.
Br J Clin Psychol 1980;36:1019-21.
20 Penk WE. Assessing the substance abuser with the MMPI. Clinical notes
on the MMPI 7. Nutley-New Jerey 1981.
21 Penk WE, Robinowitz R, Roberts M. MMPI difference of male hispanic-american,black
and white heroin addicts. J Counsult Crim Psychol 1981;49:488-90.
22 Penk WE, Robinowitz R. Personality differences of heroin addicts and
polydrug abusers. In: Craig R, Baker S, eds. Drug dependent patients:
treatment and research. Springfield: Charles Thomas III 1982:187-219.
23 Esbaugh DM, Dick KV, Tori DJ. Typological analysis of MMPI personality
patterns of drug dependent females. J Pers 1982;46:488-94.
24 Reid WH. The psychopathology: a comprehensive study of antisocial disorders
and behavior. New York 1978.
25 Gay GR, Sheppard DW. Sex in the drug culture. Med Aspects Hum Sex
1972;6:258-63.
26 Lefcourt HM, Telegdi MS. Perceived locus of control and field dependence
as predictors of cognitive activity. J Consult Clin Psychol 1971;37:53-6.
27 Felix RH. An appraisal of the personality types of the addict. Am
J Psychiatry 1944;100:462-0.
28 Glover E. On the etiology of drug addiction (1932). In: Glover E,
ed. On the Early Development of the Mind. New York: International Universities
Press 1956:187-215.
29 Cerquetelli G. La clinica psichiatrica oggi: il sé e gli stati
limite. Clinica Psichiatrica 1980;16:9-110.
30 Kernberg O. Sindromi marginali e narcisismo patologico. Torino:
Boringhieri 1978.
31 Kolb LC. Types and characteristics of drug addicts. Ment Hyg 1925;9:300-13.
32 A.P.A. DSM-III Diagnostic and Statistical Manual. 3d ed. Washington
D.C.: American Psychiatric Association 1980.
33 Clerici M, Carta I, Cazzullo CL. Substance Abuse and Psychopathology:
a diagnostic screening of italian narcotic addicts. Soc Psychiatry 1989;24:219-26.
34 Mezzich JE, Ahn CW, Fabrega H, et al. Patterns of Psychiatric Comorbidity
in a large population presenting for care. In: Maser JD, Cloninger CR,
eds. Comorbidity of Mood and Anxiety disorders. Washington DC, USA:
American Psychiatric Press 1990.
35 Arntz A, Merckelbach H, de Jong P. Opioid antagonist affects behavioral
effects of exposure in vivo. J Consult Clin Psychol 1993;61:865-70.
36 Skodol AE, Oldham JM, Gallagher PE. Axis II comorbidity of substance
abuse disorders among patients referred for treatment of personality disorders.
Am J Psychiatry 1999;156:733-8.
37 Khantzian EJ, Treece C. DSM-III psychiatric diagnosis of narcotic addicts:
Recent findings. Arch Gen Psychiatry 1985;42:1067-77.
38 Nace EP. Personality disorder in the alcoholic patient. Psych Annals
1990;19:256-60.
39 Kosten TR, Rounsaville J, Kleber HB. DSM III Personality Disorders in
opiate addicts. Compr Psychiatry 1982;23:572-81.
40 Kraepelin, E. Manic-Depressive Illness and Paranoia. Edinburgh,
UK: E&S Livingstone 1921.
41 Kleinman PH, Miller AB, Woody GE. Psychopathology among cocaine abusers
entering in treatment. J Nerv Ment Dis 1990;178:442-7.
42 Zimmerman M, Coryell W. DSM-III Personality Disorder diagnoses in a
non patient sample: demographic correlates and comorbidity. Arch Gen Psychiatry
1989;46:682-9.
43 Dulit RA, Fyer MR, Haas GL, Sullivan T, Frances AJ. Substance use in
Borderline Personality Disorders. Am J Psychiatry 1990;147:1002-7.
44 Yates WR, Fulton AI, Gabel JM, Brass CT. Personality risk factors for
cocaine abusers. Am J Public Health 1989;79:891-2.
45 Grande TP, Wolf AW, Schubert DSP, Patterson MP, Brocco K. Association
among alcoholism, drug use and antisocial personality: a review of the literature.
Psychol Rep 1984;55:455-74.
46 Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LJ, et al. Comorbidity
of mental disorders with alcohol and other drug abuse: results from the Epidemiological
Catchment Area (ECA) study. JAMA 1990;264:2511-8.
47 Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al.
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in
the United States: Results from the National Comorbidity study. Arch Gen
Psychiatry 1994;51:8-19.
48 Ross HE, Glasser FB, Germanson T. The prevalence of psychiatric disorders
in patients with alcohol and other drug problems. Arch Gen Psychiatry
1988;45:1023-32.
49 Atkinson JH, Schuckit MA. Geriatric alcohol and drug misuse and abuse.
Adv Subs Abuse 1983;3:195-237.
50 Luthar SS, Anton SF, MerinkangasKR, Rounsaville BJ. Vulnerability to
substance abuse and psychopathology among siblings of opioid abusers. J
Nerv Ment Dis 1992;180:153-61.
51 Bellodi L, Battaglia M, Migone P. Disturbo di Personalità antisociale.
Milano: Masson 1993:1997-2002.
52 Zanarini HC, Gunderson JC, Fraenkenberg FR. Axis II phenomenology of
Borderline Personality Disorder. Compr Psychiatry 1989;30:149-56.
53 Windle M. The difficult temperament in adolescence: associations with
substance use, family support, and problem behaviors. J Clin Psychol 1991;47:310-5.
54 Altermann AI, Gerstley LJ, Strohmez DB, McKay JR. Psychiatric heterogeneity
in antisocial alcoholics: relation to familiar alcoholism. Compr Psychiatry
1991;32:423-30.
55 Howard MO, Kivlahan D, Walker RD. Cloninger’s tridimensional theory
of personality and psychopathology: applications to substance use disorders.
J Stud Alcohol 1997;58:48-66.
56 Mehrabian A, O’Reilly E. Personality correlates of habitual alcohol
use. Int J Addict 1988;23:175-82.
57 Bernstein DP, Cohen P, Skodol AE, Beziganian S, Brook JS. Childhood
antecedents of adolescent personality disorders. Am J Psychiatry 1996;153:907-13.
58 Martin WR, Jasinski DR. Physiological parameters of morphine dependence
in man, early abstinence, protracted abstinence. J Psychiatr Res 1969;7:9-17.
59 Martin WR. Pathophysiology of narcotic addiction: possible role of protracted
abstinence in relapse. In: Zarafonetis CJD, ed. Drug abuse. Proceedings
of the International Conference. Philadelphia: Lea and Febiger 1972:153-9.
60 Khantzian EJ. The self-medication hypothesis of addictive disorders:
focus on heroin and cocaine dependence. Am J Psychiatry 1985;142:1259-64.
61 Woody GE, McLellan AT, Luborsky L. Sociopathy and psychotherapy outcome.
Arch Gen Psychiatry 1985;42:1081-6.
62 Rounsaville BJ, Weissman MM, Crits-Chrispoph K, Wilher K, Kleber H. Diagnosis
and symptoms of depression in opiate addicts. Arch Gen Psychiatry 1982;39:151-6.
63 Silvestrini B. Malati di droga. Le sostanze d’abuso; danni fisici e
psichici, reazione individuale, difese. Milano: Sperling e Kupfer 1995.
64 Satel SL, Edell WS. Cocaine-induced paranoia and psychosis proneness.
Am J Psychiatry 1991;148:1708-11.
65 Naditch MP. Acute adverse reaction to psychoactive drugs, drug use and
psychopathology. J Abnorm Psychol 1974;83:394-403.
66 Fabian WD, Fishkin SM. Psychological absorption:affect investment in
marijuana intoxication. J Nerv Ment Dis 1991;179:39-43.
67 de Wit H, Uhlenhuth EH, Pierri J, Johanson CE. Individual differences
in behavioral and subjective responses to alcohol. Alcohol Clin Exp Res
1987;11:52-9.
68 Zuckermann M. Sensation seeking, risk taking and health. In: Janisse
MP, ed. Individual differences, stress and health. New York, NY: Springer-Verlag
1988:72-88.
69 Cloninger CR. A systematic method for clinical description and classification
of personality variants. Arch Gen Psychiatry 1987;44:573-88.
70 Cloninger CR, Przybeck TR, Svrakic DM. The Tridimensional Personality
Questionnaire: U.S. normative data. Psychol Rep 1991;69:1047-57.
71 Zuckermann M. Sensation seeking: beyond the optimal level of arousal.
Helesdale N.J.: Erlboum 1979.
72 Benjamin JLiL, Patterson C., Greenberg BD, Murphy DL, Homer DH. Population
and familiar association between D4 dopamine receptor gene and measures of
NS. Nat Genet 1996;12:81-4.
73 Gerra G, Zaimovic A, Timpano M, Zambelli U, Delsignore R, Brambilla F.
Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology
2000;25:479-96.
74 Extein I, Pottash ALC, Gold MS. A possible opioid receptor dysfunction
in some depressive disorders. In: Verebey K, ed. Opioids in mental
illness: theories, clinical observations and treatment possibilities. Ann.
N.Y. Acad. V. 398. New York, N.Y.: The New York Academy of Sciences 1982:110-7.
75 Verebey K. Opioids in mental illness: theories, clinical observations
and treatment possibilities. New York, N.Y.: The New York Academy of Sciences
1982.
76 Block J, Block JH, Keyes S. Longitudinally foretelling drug usage in
adolescence: early childhood personality and environmental precursors.
Child Dev 1988;59:336-55.
77 Glover EG. On the aetiology of alcoholism. J Subst Abuse Treat 1984;1:120-3.
78 Rado S. The psychoanalysis of pharmacothymia (drug addiction). J
Subst Abuse Treat 1984;1:59-68.
79 Tiebout HM. Psychology and treatment of alcoholism. Quarterly Journal
of Study on Alcohol 1946-1947;7:214-27.
80 Krystal JH, Raskin HA. Drug Dependence Aspects of Ego Function.
Detroit: Wayne State University Press 1970.
81 Chein I, Gerard DL, Lee RS, et al. The road to H: narcotics, delinquency
and social policy. New York: Basic Books 1964.
82 Gerard DL, Kornetsky C. Adolescent opiate addiction: a study of control
and addict subjects. Psychoanal Q 1955;19:457-86.
83 Wurmser L. Mr. Pecksnif’s horse? In: Baine JD, Julius DA, eds. Psychodynamics
of drug dependence. Rockville, MD: U.S. Dept. of Health Education Welfare
1977:36-72.
84 Khantzian EJ. Psychoterapeutic interventions with substance abusers:
the clinical contest. J Subst Abuse Treat 1985;2:83-8.
85 Kohut H. The analysis of the self. New York, NY: International Universities
Press 1971.
86 Wieder H, Kaplan EH. Drug use in adolescents: psychodynamic meaning
and pharmacogenic effect. Psychoanal Study Child 1969;24:399-431.
87 Kaplan CD, Wogan M. The psychoanalytic theory of addiction: A reevaluation
by use of a statistical model. Am J Psychoanal 1978;38:317-26.
88 Milkman H, Frosch W. On the preferential abuse of heroin and amphetamines.
J Nerv Ment Dis 1973;1564:242-8.
89 Beck AT, Wright FD, Newman CF, Liese BS. Cognitive Therapy of Substance
Abuse. New York, NY: Guilford Press 1993.
90 Fischman MW, Foltin RW. Self-administration of cocaine for humans: a
laboratory perspective. In: Fischman MW, Foltin RW, eds. Cocaine: scientific
and social dimensions. New York: John Wiley and sons 1992:165-80.
91 Vaillant GE. The Natural History of alcoholism: causes, patterns, and
paths to recovery. Cambridge: Mass. Harvard University Press 1983.
92 McLellan AT, Luborsky L, Woody GE, Druley KA, O’Brien CP. Predicting
response to alcohol and drug abuse treatments: role of psychiatric severity.
Arch Gen Psychiatry 1983;40:620-5.
93 McLellan AT, Arndt IO, Metzger DS, Woody GE, O’Brien CP. The effects
of psychological services in substance abuse treatment. JAMA 1993;269:1953-9.
94 McLellan AT. "Psychiatric severity" as a predictor of outcome
from substance abuse treatments. In: Meyer RE, ed. Psychopathology
and Addictive Disorders. New York: Guilford Press 1986:85-93.
95 Rounsaville BJ, Weissman MM, Kleber H, Wilber C. Heterogeneity of psychiatric
diagnosis in treated opiate addicts. Archives of General Psychiatry 1982;39:161-6.
96 Hesselbrock MN, Meyer RE, Keener JJ.
Psychopathology in hospitalized alcoholics.
Arch Gen Psychiatry 1985;42:1050-5.
97 Penick EC, Powell BJ, Liskow B, Jackson JO, Nickel EJ. The stability
of coexisting psychiatric syndromes in alcoholic men after one year. J
Stud Alcohol 1988;49:395-405.
98 Wieland WF, Sola S. Depression in opiate addicts measured by objective
tests. In: N.A.P.A.N. ed. Proceedings of the III National Conference
on Methadone Treatment. New York, N.Y.: The Association 1970:187-202.
99 Lehman WX, De Angelis GC. Adolescents, methadone, and psychoterapeutic
agents. Proceedings of the Fourth National Conference on Methadone
Treatment. New York, NY: National Association for the Prevention of the
Addiction to Narcotics 1972:95-104.
100 Robins PR. Depression and drug addiction. Psychoanal Q 1974;48:375-86.
101 Weissman MM, Slobetz F, Prusoff BA, Mesritz M, Howard PAT. Clinical
depression among narcotic addicts maintained on methadone in the community.
Am J Psychiatry 1976;133:1434-8.
102 Senay EC. Multimodality programming in Illinois: evolution of a public
health concept. In: Lowinson JH, Ruiz P, eds. Substance Abuse: Clinical
Problem and Perspectives. Baltimore, ML: Williams and Wilkins 1981:365-82.
103 Rounsaville BJ, Weissman MM, Rosenberger PH, Wilbur CH, Kleber HD. Detecting
depressive disorders in drug abusers: a comparison of screening instruments.
J Affect Disord 1979;1:255-67.
104 Steer RA, Kotzer E. Affective changes in male and female methadone
patients. Drug and Alcohol Dependence 1980;5:115-22.
105 McLellan AT, O’Brien CP, Kron R, Druley KA, Alterman AI. Matching substance
abuse patients to appropriate treatments. Drug Alcohol Depend 1980;5:189-95.
106 Hendriks WJ. Use of multifamily counseling groups in treatment of male
narcotics addicts. Int J Group Psychother 1971;21:34-90.
107 Jainchill N, De Leon G, Pinkham L. Psychiatric diagnosis among substance
abusers in therapeutic community treatment. J Psychoactive Drugs 1986;18/3:209-13.
108 Khantzian EJ, Treece CD. Heroin addiction: the diagnostic dilemma for
Psychiatry. In: Pickens RW, Heston LL, eds. Psychiatric Factors in
Drug Abuse. New York, NY: Grune and Stratton 1979:21-45.
109 O’Doherty F, Davies JB. Life events and addiction: a critical review.
Br J Addict Alcohol Other Drugs 1987;82/2:127-37.
110 Woody GE, McLellan AT, Luborsky L, O’Brien CP. Psychiatric severity
as a predictor of benefits from psychotherapy: The Penn-VA study. Am J
Psych 1984;141:1172-7.
111 Inman DJ, Bascue LO, Scoloda T. Identifications of borderline personality
disorders among substance abuse in-patients. J Subs Abuse Treat 1985;2/4:229-32.
112 Pope HG. Drug Abuse and Psychopatology. N Engl J Med 1979;301/24:1341-2.
113 Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber CH, Kleber HB.
Diagnosis and symptoms of depression in opiate addicts: Course and relationship
to treatment outcome. Arch Gen Psychiatry 1982;39:156-61.
114 De Jong AJ, Van Den Brink W, Hartveld FM. Personality Disorders in
Alcoholics and Drug Addicts. Compr Psychiatry 1996;34:87-94.
115 Dackis CA, Gold MS. Opiate addiction and depression: Cause or effect.
Drug Alcohol Depend 1983;11:105-9.
116 Clerici M, Capitanio C, Garini R, Carta I. Tossicodipendenza ed interventi
psicoterapeutici: Il profilo psicopatologico del tossicodipendente da eroina.
Arch Psicol Neurol Psichiatr 1987;48:546-59.
117 Mintz J, O’Brien CP, Woody GE, Beck AT. Depression in treated narcotic
addicts, ex addicts, non addicts, and suicide attempters: Validation of a
very brief depression scale. Am J Drug Alcohol Abuse 1979;6:385-96.
118 Pilowsky I, Katsikitis M. Depressive illness and dependency. Acta
Psychiatr Scand 1983;68:11-4.
119 Shaw BF, Steer RA, Beck AT, Schut J. Structure of depression in heroin
addicts. Br J Addict 1979;74:295-303.
120 Bela GLA, Folke J, Von Knorring L, Terenius L, Wahlstrom A. Endorphins
in chronic pain. Differences in CSF endorphin levels between organic and psychogenic
pain syndromes. Pain 1978;5:153-62.
121 Woody GE, Blaine JD. Depression in narcotic addicts: Quite possibly
more than a chance association. In: Dupont RL, Goldstein A, O’Donnell
J, eds. Handbook on Drug Abuse. National Institute on Drug Abuse Pub.
No.277-286. Washington, D.C.: U.S. Govt. Print. Off. 1979:175-91.
122 Rounsaville BJ, Rosenberger PH, Wilber CH, Weissman MM, Kleber HD. A
comparison of the SAD/RDC and the DSM-III, Diagnosing drug abusers. J
Nerv Ment Dis 1980;168:90-7.
123 Rounsaville BJ, Cacciola J, Weissman MM, Kleber HD. Diagnostic concordance
in a follow-up study of opiate addicts. J Psychiatr Res 1981;16:191-201.
124 Rounsaville BJ, Weissman MM, Wilber CH, Kleber HD. The heterogeneity
of psychiatry disorders in treated opiate addicts. Arch Gen Psychiatry
1982;39:161-6.
125 Rounsaville BJ, Weissman MM, Kleber HD. An evaluation of depression
in opiate addicts. Research Communications in Mental Health 1983;3:257-89.
126 Rounsaville BJ, Eyre S, Weissman MM, Kleber HD. The antisocial opiate
addict. Adv Alcohol Subst Abuse 1983;2:29-42.
127 Rounsaville BJ. Epidemiology of drug use and abuse in adults. In:
Cavenar JO, ed. Psychiatry. New York: Basic Books Inc 1985:137-43.
128 Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Evaluating and Treating
Depressive Disorders in Opiate Addicts. Rockville, Maryland: NIDA National
Institute on Drug Abuse 1985.
129 Rounsaville BJ, Kleber HD. Psychiatric disorders in opiate addicts:
preliminary findings on the cause and interaction with program type. In:
Meyer RE, ed. Psychopathology and Addictive Disorders. New York: Guilford
1986:140-68.
130 Rounsaville BJ, Kosten TR, Kleber HD. Long-term changes in current
psychiatric diagnoses of treated opiate addicts. Compr Psychiatry 1986;27:480-98.
131 Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as
a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry 1987;44:505-13.
132 Mirin SN, Weiss RD, Griffin ML, Michael JL. Psychopathology in drug
abusers and their families. Compr Psychiatry 1991;32:36-51.
133 Mirin SM, Weiss R, Michael J, Griffin M. Psychopathology in substance
abusers: Diagnosis and treatment. Am J Drug Alcohol Abuse 1988;14:139-57.
134 Mirin SM, Weiss RD. Psychiatric Comorbidity in Drug/Alcohol Addiction.
In: Miller NS, ed. Comprehensive Handbook of Drug and Alcohol Addiction.
White Plains, New York: Mercel Dekker, Inc 1991:65-77.
135 Volovka SJ, Anderson B, Koz G. Naloxone and naltrexone in mental illness
and tardive dyskinesia. In: Verebey K, ed. Opioids in mental illness:
theories, clinical observations and treatment possibilities. Ann. N. Y. Acad.
V. 398. New Yorl, N.Y.: The New York Academy of sciences 1982:143-52.
136 Castaneda R, Galanter M, Franco H. Self-medication among addicts with
primary psychiatric disorders. Compr Psychiatry 1989;30:80-3.
137 Khantzian EJ. Opiate addiction: A critique of theory and some implications
for treatment. Am J Psychother 1974;28:59-70.
138 Wurmser L. Psychoanalytic considerations of the etiology of compulsive
drug abuse. American Psychoanalitic Association 1974;22:820-43.
139 Maremmani I, Zolesi O, Aglietti M, Marini G, Tagliamonte A, Shinderman
M, et al. Methadone Dose and Retention in Treatment of Heroin Addicts with
Axis I Psychiatric Comorbidity. J Addict Dis 2000;19:29-41.
140 Himmelhoch JM, Mulla D, Neil JF, Detre TP, Kupfer DJ. Incidence and
significance of mixed affective states in a bipolar population. Arch Gen
Psychiatry 1976;33:1062-7.
141 Brady KT, Sonne SC. The relationship between substance abuse and bipolar
disorder. J Clin Psychiatry 1995;56:19-24.
142 Winokur G, Coryell W, Akiskal HS, Maser J, Keller MB, Endicott J, et al.
Alcoholism in Manic-Depressive (Bipolar) illness: familial illness, course
of illness and the primary-secondary distinction. Am J Psychiatry 1995;152:365-72.
143 Maremmani I, Capone MR, Aglietti M, Castrogiovanni P. Heroin dependence
and Bipolar Disorders. New Trends in Experimental and Clinical Psychiatry
1994;X:179-82.
144 Martin WR, Jasinski DR, Mansky PA. Naltrexone, an antagonist for the
treatment of heroin dependence. Arch Gen Psychiatry 1973;28:784-91.
145 Sideroff SN, Charauwasta VC, Farvik ME. Craving in heroin addicts maintained
on the opiate antagonist Naltrexone. Am J Drug Alcohol Abuse 1978;5:415-23.
146 Resnick RB, Schuyten E, Cooper L, Schwartz L. Narcotic antagonists:
a point of view concerning treatment approaches. Presented at the National
Institute on Drug Abuse, Narcotic Antagonist Clinical 1974.
147 Pacini M. Personalità, temperamento e uso di sostanze. Revisione
della letteratura e contributo sperimentale. Pisa: Tesi di Laurea in Medicina
1998-1999.
148 Maremmani I, Lazzeri A, Canoniero S, Aglietti M, Placidi GF. Abuso
di Sostanze e Psicosi Croniche. Giorn Ital di Psicopatol 1999;5:290-303.
149 Perugi G, Frare F, Madaro D, Maremmani I, Akiskal HS. Alcohol abuse
in social phobic patients: is there a bipolar connection? J Affect Disord
(in press).
150 Perretta P, Akiskal HS, Nisita C, Lorenzetti C, Zaccagnini E, Della Santa
M, et al. The high prevalence of bipolar II and associated cyclothymic
and hyperthymic temperaments in HIV-patients. J Affect Disord 1998;50:215-24.
151 Vaillant GE. A twelve-year follow-up of New York narcotic addicts,
IV: Some characteristics and determinants of abstinence. Am J Psychiatry
1966;123:575-85.
152 Craig RJ. The personality structure of heroin addicts. In: Szara
SI, ed. Neurobiology of Behavioral Control in Drug Abuse. NIDA Research
Monograph Series n° 74. Rockville, Maryland: NIDA 1986:327-68.